220 related articles for article (PubMed ID: 18174171)
1. Novel inhibitors for murine and human leukemia inhibitory factor based on fused soluble receptors.
Metz S; Naeth G; Heinrich PC; Müller-Newen G
J Biol Chem; 2008 Mar; 283(10):5985-95. PubMed ID: 18174171
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the Interleukin (IL)-6 Inhibitor IL-6-RFP: fused receptor domains act as high affinity cytokine-binding proteins.
Metz S; Wiesinger M; Vogt M; Lauks H; Schmalzing G; Heinrich PC; Müller-Newen G
J Biol Chem; 2007 Jan; 282(2):1238-48. PubMed ID: 17085445
[TBL] [Abstract][Full Text] [Related]
3. Nanoluciferase as a novel quantitative protein fusion tag: Application for overexpression and bioluminescent receptor-binding assays of human leukemia inhibitory factor.
He SX; Song G; Shi JP; Guo YQ; Guo ZY
Biochimie; 2014 Nov; 106():140-8. PubMed ID: 25179300
[TBL] [Abstract][Full Text] [Related]
4. The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.
Adrian-Segarra JM; Schindler N; Gajawada P; Lörchner H; Braun T; Pöling J
J Biol Chem; 2018 May; 293(18):7017-7029. PubMed ID: 29511087
[TBL] [Abstract][Full Text] [Related]
5. Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.
Walker EC; Johnson RW; Hu Y; Brennan HJ; Poulton IJ; Zhang JG; Jenkins BJ; Smyth GK; Nicola NA; Sims NA
J Biol Chem; 2016 Oct; 291(41):21703-21716. PubMed ID: 27539849
[TBL] [Abstract][Full Text] [Related]
6. Engineered interleukin-6-derived cytokines recruit artificial receptor complexes and disclose CNTF signaling via the OSMR.
Rafii P; Cruz PR; Ettich J; Seibel C; Padrini G; Wittich C; Lang A; Petzsch P; Köhrer K; Moll JM; Floss DM; Scheller J
J Biol Chem; 2024 May; 300(5):107251. PubMed ID: 38569939
[TBL] [Abstract][Full Text] [Related]
7. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
[TBL] [Abstract][Full Text] [Related]
8. Leukemia inhibitory factor functions as a growth factor in pancreas carcinoma cells: Involvement of regulation of LIF and its receptor expression.
Kamohara H; Ogawa M; Ishiko T; Sakamoto K; Baba H
Int J Oncol; 2007 Apr; 30(4):977-83. PubMed ID: 17332938
[TBL] [Abstract][Full Text] [Related]
9. Gp130 cytokines exert differential patterns of crosstalk in adipocytes both in vitro and in vivo.
White UA; Stewart WC; Stephens JM
Obesity (Silver Spring); 2011 May; 19(5):903-10. PubMed ID: 21164505
[TBL] [Abstract][Full Text] [Related]
10. p42/p44-MAPK and PI3K are sufficient for IL-6 family cytokines/gp130 to signal to hypertrophy and survival in cardiomyocytes in the absence of JAK/STAT activation.
Fahmi A; Smart N; Punn A; Jabr R; Marber M; Heads R
Cell Signal; 2013 Apr; 25(4):898-909. PubMed ID: 23268184
[TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of leukemia inhibitory factor receptor antagonists as candidate therapeutics for inflammatory arthritis.
Jazayeri JA; De Weerd N; Raye W; Kivivuori S; Zabihi E; Carroll GJ
J Interferon Cytokine Res; 2007 Apr; 27(4):281-9. PubMed ID: 17477816
[TBL] [Abstract][Full Text] [Related]
12. An unusual cytokine:Ig-domain interaction revealed in the crystal structure of leukemia inhibitory factor (LIF) in complex with the LIF receptor.
Huyton T; Zhang JG; Luo CS; Lou MZ; Hilton DJ; Nicola NA; Garrett TP
Proc Natl Acad Sci U S A; 2007 Jul; 104(31):12737-42. PubMed ID: 17652170
[TBL] [Abstract][Full Text] [Related]
13. Oncostatin M is a growth factor for Ewing sarcoma.
David E; Tirode F; Baud'huin M; Guihard P; Laud K; Delattre O; Heymann MF; Heymann D; Redini F; Blanchard F
Am J Pathol; 2012 Nov; 181(5):1782-95. PubMed ID: 22982441
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of gp130 cytokine effects on corticotroph AtT-20 cells--redundancy or specificity of neuroimmunoendocrine modulators?
Auernhammer CJ; Kopp FB; Vlotides G; Dorn F; Isele NB; Spöttl G; Cengic N; Weber MM; Senaldi G; Engelhardt D
Neuroimmunomodulation; 2004; 11(4):224-32. PubMed ID: 15249728
[TBL] [Abstract][Full Text] [Related]
15. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
Plun-Favreau H; Perret D; Diveu C; Froger J; Chevalier S; Lelièvre E; Gascan H; Chabbert M
J Biol Chem; 2003 Jul; 278(29):27169-79. PubMed ID: 12707269
[TBL] [Abstract][Full Text] [Related]
16. gp130 Cytokines Activate Novel Signaling Pathways and Alter Bone Dissemination in ER+ Breast Cancer Cells.
Omokehinde T; Jotte A; Johnson RW
J Bone Miner Res; 2022 Feb; 37(2):185-201. PubMed ID: 34477239
[TBL] [Abstract][Full Text] [Related]
17. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of the JAK/STAT pathway by LIF and OSM in the human granulosa cell line COV434.
Pastuschek J; Poetzsch J; Morales-Prieto DM; Schleußner E; Markert UR; Georgiev G
J Reprod Immunol; 2015 Apr; 108():48-55. PubMed ID: 25817464
[TBL] [Abstract][Full Text] [Related]
19. A functional role of the membrane-proximal extracellular domains of the signal transducer gp130 in heterodimerization with the leukemia inhibitory factor receptor.
Timmermann A; Küster A; Kurth I; Heinrich PC; Müller-Newen G
Eur J Biochem; 2002 Jun; 269(11):2716-26. PubMed ID: 12047380
[TBL] [Abstract][Full Text] [Related]
20. The immunoglobulin-like module of gp130 is required for signaling by interleukin-6, but not by leukemia inhibitory factor.
Hammacher A; Richardson RT; Layton JE; Smith DK; Angus LJ; Hilton DJ; Nicola NA; Wijdenes J; Simpson RJ
J Biol Chem; 1998 Aug; 273(35):22701-7. PubMed ID: 9712900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
